Relay Therapeutics is a biotechnology company based in Cambridge, Massachusetts. It specializes in precision medicine, using computational and experimental techniques to develop targeted therapies for diseases like cancer and genetic disorders. Relay Therapeutics' Dynamo Platform focuses on protein motion to identify and optimize drug candidates. The company collaborates with leading pharmaceutical firms and is advancing a pipeline of innovative treatments. It is committed to transforming drug discovery and improving patient outcomes.